Royalty Pharma Plc (RPRX) Institutional Ownership and Insiders Activity
Royalty Pharma Plc (RPRX) is widely held by institutional investors, with 629 firms reporting positions valued at approximately $20.29B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Morgan Stanley is the largest disclosed holder, reporting approximately $2.41B in RPRX holdings in its latest filing.
Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
629
Total Reported Value
$20.29B
Largest Holder
Morgan Stanley
Largest Position
$2.41B
Insider Transactions (90d)
12
Latest Filing Quarter
Q2 2026
New Institutional Positions
0
Funds Exiting Positions
613
Top Institutional Owners
View all- Morgan Stanley$2.41B
- Capital International Investors$1.98B
- Blackrock, Inc.$1.56B
- Fmr Llc$1.37B
- State Street Corp$691.80M
RPRX News
All news- Caledonia Private Investments Pty Ltd Q2 2026: Significant Activity in COUR, RKT and FLUT Observed
Aug 19, 2026 · valut.ai
- Pat Dorsey Q2 2026 Investment Activity: Focus on Technology and Select Sector Adjustments
Aug 17, 2026 · valut.ai
- New South Capital Management Inc Q2 2026 Portfolio Changes: Strategic Shifts in Industrials, Technology and Consumer Cyclical Sectors
Aug 12, 2026 · valut.ai
- Inlet Private Wealth Q2 2026 Portfolio Activity: Strategic Shifts in Tech and Financial Services
Aug 10, 2026 · valut.ai
- Psp Research Llc Portfolio Analysis: Q2 2026 Investment Activity
Jul 12, 2026 · valut.ai
- Cooper Investors Pty Ltd Q2 2026 Investment Activity
Jul 9, 2026 · valut.ai